Elligo Health Research is revolutionizing the clinical research industry with a novel approach to common trial challenges including patient participation and enrollment, and physician participation. Founded by Chad Moore in 2016, Elligo Health Research is backed by investors that include Excelerate Health Ventures, Hatteras Venture Partners, Noro-Moseley Partners, Piper Jaffray Merchant Banking, and Shumway Capital and is headquartered in Austin.